Vibe Bioscience Ltd stock analysis
Want to see TSE:VIBE full AI Analyst Report?
Vibe Bioscience Ltd (VIBE) Stock Price & Analysis
VIBE Stock Chart & Stats
- Day’s Range
- CAD 0.63 - CAD 0.63
- 52-Week Range
- CAD 0.30 - CAD 0.65
- Previous Close
- CAD 0.63
- Volume
- N/A
- Average Volume (3M)
- 175
- Market Cap
- CAD 680.21K
- Enterprise Value
- CAD 2.56M
- Total Cash (Recent Filing)
- CAD 835.52K
- Total Debt (Recent Filing)
- CAD 2.30M
- Price to Earnings (P/E)
- ―
- Beta
- 2.37
- Next Earnings
- Nov 26, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Operating Rebound
The latest period shows a meaningful operating recovery, with revenue growth accompanied by positive EBIT and EBITDA margins. If this improvement persists, it could strengthen internal funding capacity, support reinvestment, and improve the company’s ability to build more durable earnings power.
Positive Operating And Free Cash Flow
Positive operating and free cash flow indicate that the business is currently generating cash despite reporting a net loss. This provides greater flexibility to support operations and investment, although continued positive conversion will be important for establishing a sustainable financial foundation.
Steady Gross Margins
Relatively stable gross margins suggest the company has maintained its underlying economics while operations improved. Margin consistency can help make future revenue growth more valuable, provide a base for operating leverage, and reduce dependence on exceptionally favorable pricing or cost conditions.
Bears Say
Negative Shareholders’ Equity
Negative equity materially limits financial flexibility and indicates that the company’s accumulated financial position remains weak. It can increase dependence on external funding, raise dilution or refinancing risk, and restrict the resources available to absorb setbacks or finance growth.
Continuing Net Losses
The company has not yet converted its operational rebound into bottom-line profitability. Continued net losses can consume financial resources, weaken retained capital, and make the recent margin improvement less durable unless revenue growth and operating gains continue to outweigh remaining costs.
Cash-flow Consistency Risk
Although the latest period produced positive operating and free cash flow, the historical swings show that cash generation has not yet been demonstrated consistently. Future funding flexibility therefore remains sensitive to operating volatility and the company’s ability to sustain recent improvements.
Vibe Bioscience Ltd News
VIBE FAQ
What was Vibe Bioscience Ltd’s price range in the past 12 months?
What is Vibe Bioscience Ltd’s market cap?
When is Vibe Bioscience Ltd’s upcoming earnings report date?
How were Vibe Bioscience Ltd’s earnings last quarter?
Is Vibe Bioscience Ltd overvalued?
Does Vibe Bioscience Ltd pay dividends?
What is Vibe Bioscience Ltd’s EPS estimate?
How many shares outstanding does Vibe Bioscience Ltd have?
What happened to Vibe Bioscience Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Vibe Bioscience Ltd?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Vibe Bioscience Ltd
Vibe Growth Corp. is a vertically integrated cannabis company. The firm operates retail dispensaries, cannabis greenhouse and indoor cultivation, commercial distribution and transportation, e-commerce and home delivery, and manufacturing of marijuana products. It operates through the following segments: Dispensaries, Cultivation, Real Estate, and Canada. The company was founded on January 19, 2011 and is headquartered in Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mark William Waldron
- Employees
- 165
- Website
- www.vibebycalifornia.com
- Address
- #250, 997 Seymour St., Vancouver, BC, V6B 3M1, CA
Vibe Bioscience Ltd (VIBE) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 3 | 3 |
| Technical Analysis | 4 | 2 | 1 |
| Moving Averages | 9 | 1 | 2 |



